Delivery Order SPE2DE24DA017-SPE2D625F0KQ1
- Not listed
- This delivery order, valued at $3,131.04, was awarded on August 21, 2025, to Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies. The order is issued under the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency, with a completion deadline of August 26, 2025. The contract utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation, reflecting Arthrex's competitive standing...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $3,495.40 from the Defense Logistics Agency's Medical Supply Chain on May 8, 2025. The order, issued under contract number 4568194464, is for KL 1.8 Fibertak shoulder products and is structured as a fixed-price delivery order with economic price adjustment provisions. The work is scheduled for completion by May 22, 2025, and will be performed at Arthrex's...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order valued at $1,321.32 from the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, with completion scheduled for September 12, 2025. This fixed-price delivery order with economic price adjustment mechanism is issued under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and spanning from June 11, 2024,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,980.00 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 18, 2025. This fixed-price delivery order with economic price adjustment authority (Contract Number 4568979999) was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $2,070.84 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The delivery order, designated as SP FBRTAK RC TGRTPE WH/BLK & STTPE WH/BL, calls for specialized orthopedic products with an ultimate completion date of July 3, 2025. This award was not set aside for any specific business type, reflecting Arthrex's strong competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $2,437.38 from the Defense Logistics Agency's Medical Supply Chain on May 20, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by May 29, 2025, and represents work performed under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order valued at $6,586.92 from the Defense Logistics Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment, designated as IMPL SYS, MPFL, FASTTHREAD, represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $3,025.44 delivery order on August 1, 2025, with an ultimate completion date of August 6, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal program supporting government healthcare systems. The contract carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $6,808.01 from the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with completion targeted for August 29, 2025. This fixed-price contract with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running through...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0KQ1Delivery Order
This delivery order (4568423678) valued at $1,965.65 was awarded to Arthrex Inc. on June 3, 2025, by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract represents a fixed-price delivery order with economic price adjustment provisions and is set to be completed by June 6, 2025. Arthrex, a Naples, Florida-based global leader in minimally invasive orthopedic medical technologies, will perform work at its Naples facility. The company specializes in developing and supplying advanced orthopedic surgical implants, instruments, and biologics to government healthcare systems. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 1, 2029. That comprehensive IDC enables Veterans Affairs medical centers and Department of Defense facilities nationwide to acquire Arthrex's full portfolio of orthopedic solutions, including surgical implants, arthroscopic instruments, joint replacement technologies, and specialized surgical instrument systems. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/3/25 |